Congressional Action Needed To Protect Device Supply Chain, FDA’s Woodcock Says
Executive Summary
The US FDA needs enhanced authorities as well as increased funding to track and prevent device shortages, acting commissioner Janet Woodcock argues.
You may also be interested in...
Heads Of HHS, FDA Outline Biden's Budget Proposals To US Congress
US President Joe Biden’s proposed budget for fiscal 2022 allocates $133.7bn for HHS, a 23% increase for the department from fiscal 2021; the administration is also asking for $6.5bn for the FDA, an 8% increase from the agency’s current budget.
Unpacking The $2.2Tn Stimulus Act: Boosts To Medtech And Diagnostics To Fight Coronavirus
A $2.2tn coronavirus stimulus package signed into law by President Trump on 27 March will distribute billions of dollars to federal agencies – including the FDA, the CDC and the FEMA – to hasten approvals of new diagnostics, medical ventilators, respirators and other medtech supplies, conduct more testing of potential COVID-19 patients, and quickly distribute medical supplies where needed most.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.